title: Treatment of predialysis patients with recombinant human erythropoietin.
authors.affiliation: Department of Medicine, University Hospital, Nijmegen, The Netherlands.
authors.forename: R A
authors.initials: RA
authors.lastname: Koene
authors.forename: L A
authors.initials: LA
authors.lastname: Frenken
authors.forename: J F
authors.initials: JF
authors.lastname: Wetzels
authors.forename: H E
authors.initials: HE
authors.lastname: Sluiter
authors.forename: G
authors.initials: G
authors.lastname: Schrijver
authors.forename: R
authors.initials: R
authors.lastname: Verberckmoes
authors.forename: P
authors.initials: P
authors.lastname: Michielsen
mesh_terms: D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy / Q000628:therapy; D006435:Renal Dialysis
chemical_list: D006454:Hemoglobins; D004921:Erythropoietin